McClellan William D. Jr.
Insider CIK 1689402 · APEN Director · RETA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 6,300 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 99 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 416 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,620 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 135 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 2,137 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 4,500 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 9,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 8,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 2,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 6,017 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-28 | 2023-08-01 | 5,000 | — | $0 | 4,500 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2023-07-28 | 2023-08-01 | 5,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-28 | 2023-08-01 | 5,000 | $26.46 | $132.3K | 5,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2023-07-28 | 2023-08-01 | 5,000 | — | $0 | 11,017 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-07-28 | 2023-08-01 | 5,000 | $164.49 | $822.5K | 6,017 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 135 | $73.68 | $9.9K | 135 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 2,137 | — | $0 | 2,137 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-07 | 2023-06-09 | 1,682 | $93.61 | $157.5K | 6,017 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-07 | 2023-06-09 | 106 | $93.61 | $9.9K | 4,335 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 19,333 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 1,437 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 4,844 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 5,271 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 28,446 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 16,536 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 9,848 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 2,000 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 39,249 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 19,333 | — | $0 | 19,333 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award | 2022-06-14 | 2022-06-16 | 14,224 | — | $0 | 39,249 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-09 | 416 | $24.02 | $10.0K | 416 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-09 | 5,620 | — | $0 | 5,620 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-06-08 | 2022-06-09 | 3,883 | $34.76 | $135.0K | 4,229 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-06-08 | 2022-06-09 | 287 | $34.76 | $10.0K | 346 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-01-03 | 2022-01-05 | 99 | $16.14 | $1.6K | 99 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 59 | $27.32 | $1.6K | 59 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 5,271 | $8.86 | $46.7K | 66,382 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award | 2021-06-17 | 2021-06-21 | 3,888 | — | $0 | 25,025 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-12 | 2020-11-13 | 4,000 | $25.52 | $102.1K | 4,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2020-11-12 | 2020-11-13 | 4,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-12 | 2020-11-13 | 4,000 | — | $0 | 2,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2020-11-12 | 2020-11-13 | 488 | $174.82 | $85.3K | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2020-11-12 | 2020-11-13 | 2,542 | $172.44 | $438.3K | 1,458 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2020-11-12 | 2020-11-13 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2020-11-12 | 2020-11-13 | 970 | $173.21 | $168.0K | 488 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-09 | 2020-11-10 | 1,500 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-09 | 2020-11-10 | 2,500 | — | $0 | 9,500 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2020-11-09 | 2020-11-10 | 4,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-09 | 2020-11-10 | 2,500 | $26.46 | $66.2K | 4,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-09 | 2020-11-10 | 1,500 | $26.46 | $39.7K | 1,500 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2020-11-09 | 2020-11-10 | 4,000 | $150.01 | $600.0K | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2020-11-09 | 2020-11-10 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-22 | 6,300 | — | $0 | 6,300 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award deriv | 2020-05-07 | 2020-05-11 | 28,446 | $2.08 | $59.2K | 61,111 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award | 2020-05-07 | 2020-05-11 | 10,257 | — | $0 | 21,137 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award deriv | 2019-08-16 | 2019-08-20 | 16,536 | $3.27 | $54.1K | 32,665 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award | 2019-08-16 | 2019-08-20 | 5,399 | — | $0 | 10,880 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2019-06-12 | 2019-06-13 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2018-06-13 | 2018-06-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award deriv | 2018-02-28 | 2018-03-02 | 9,848 | $6.58 | $64.8K | 9,848 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award | 2018-02-28 | 2018-03-02 | 2,873 | — | $0 | 5,481 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2017-06-14 | 2017-06-15 | 6,000 | — | $0 | 6,000 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | J Other deriv | 2017-05-25 | 2017-05-30 | 4,844 | $6.50 | $31.5K | 4,844 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award | 2017-05-25 | 2017-05-30 | 2,608 | — | $0 | 2,608 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-05-17 | 2017-05-18 | 1,200 | $6.42 | $7.7K | 2,000 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-05-17 | 2017-05-18 | 500 | $6.18 | $3.1K | 800 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-05-17 | 2017-05-30 | 1,700 | $6.35 | $10.8K | 2,000 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-05-16 | 2017-05-18 | 300 | $6.19 | $1.9K | 300 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-05-16 | 2017-05-30 | 300 | $6.19 | $1.9K | 300 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2017-03-01 | 2017-03-02 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2017-03-01 | 2017-03-02 | 1,500 | — | $0 | 1,500 | SEC↗ |
| APEN LPATH, INC | J Other deriv | 2016-12-29 | 2016-12-30 | 1,437 | — | $0 | 1,437 | SEC↗ |